John Lenehan

936 total citations
21 papers, 358 citations indexed

About

John Lenehan is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, John Lenehan has authored 21 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in John Lenehan's work include Cancer Immunotherapy and Biomarkers (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). John Lenehan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Colorectal Cancer Treatments and Studies (5 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). John Lenehan collaborates with scholars based in Canada, United States and Poland. John Lenehan's co-authors include Saman Maleki Vareki, Mithunah Krishnamoorthy, Wendy A. Teft, Stephen Welch, Yun‐Hee Choi, Eric Winquist, James S. Duncan, Lee M. Graves, Maria Bretner and Timothy Haystead and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

John Lenehan

20 papers receiving 356 citations

Peers

John Lenehan

ONCOL

EPIDE

SURGE

GENET

Ximao Cui China

Carolyn A. Goard Canada

Williams Fajardo Peru

Li Ren China

Mushtaq Ashraf Pakistan

Tianhui Zou China

Yumi Wanifuchi‐Endo Japan

Christopher L. Seiler United States

Lidija Beketić-Orešković Croatia

Brittney S. Harrington United States

Ximao Cui China

John Lenehan

125 ×0.7

ONCOL

338 ×2.2

92 ×1.8

EPIDE

46 ×1.1

SURGE

65 ×1.9

GENET

Citations per year, relative to John Lenehan John Lenehan (= 1×) peers Ximao Cui

Countries citing papers authored by John Lenehan

Since Specialization

Citations

This map shows the geographic impact of John Lenehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lenehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lenehan more than expected).

Fields of papers citing papers by John Lenehan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lenehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lenehan. The network helps show where John Lenehan may publish in the future.

Co-authorship network of co-authors of John Lenehan

This figure shows the co-authorship network connecting the top 25 collaborators of John Lenehan. A scholar is included among the top collaborators of John Lenehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lenehan. John Lenehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baines, Kelly J., Wilson H. Miller, Rahima Jamal, et al.. (2025). Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial. Journal for ImmunoTherapy of Cancer. 13(8). e012659–e012659. 2 indexed citations

Elkrief, Arielle, Siddhartha P. Duttagupta, Nicolas Marcoux, et al.. (2024). 1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate). Annals of Oncology. 35. S707–S708. 11 indexed citations

Kartolo, Adi, Wilma M. Hopman, Linda Liu, et al.. (2022). Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. Current Oncology. 29(3). 1501–1513. 1 indexed citations

Miller, Wilson H., Bertrand Routy, Rahima Jamal, et al.. (2022). Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma.. Journal of Clinical Oncology. 40(16_suppl). 9533–9533. 8 indexed citations

Teft, Wendy A., John Lenehan, Sisira Sarma, et al.. (2021). Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events. Clinical and Translational Science. 14(4). 1338–1348. 33 indexed citations

Kartolo, Adi, et al.. (2021). Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma. Journal of Immunotherapy. 44(4). 167–174. 15 indexed citations

Litchfield, David W., Laszlo Gyenis, Timothy Haystead, et al.. (2021). An Unbiased Evaluation of CK2 Inhibitors by Chemoproteomics: Characterization of Inhibitor Effects on CK2 and Identification of Novel Inhibitor Targets. UNC Libraries. 1 indexed citations

Lenehan, John, et al.. (2020). P864 Combination of fecal microbiota transplantation from healthy donors with anti-PD1 immunotherapy in treatment-naïve advanced or metastatic melanoma patients. Poster presentations. A11–A12. 10 indexed citations

Krishnamoorthy, Mithunah, John Lenehan, & Saman Maleki Vareki. (2020). Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges. JNCI Journal of the National Cancer Institute. 113(7). 823–832. 47 indexed citations

10.

Borrie, Adrienne E., Yun‐Hee Choi, Francisco Perera, et al.. (2020). Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast Cancer Research and Treatment. 183(2). 365–372. 11 indexed citations

11.

Krishnamoorthy, Mithunah, John Lenehan, Jeremy P. Burton, & Saman Maleki Vareki. (2020). Immunomodulation in Pancreatic Cancer. Cancers. 12(11). 3340–3340. 11 indexed citations

12.

Teft, Wendy A., John Lenehan, Robin J. Francis, et al.. (2019). Prospective cohort study of the impact of hospital-wide dihydropyrimidine dehydrogenase (DPYD) genotype testing for fluoropyrimidine-based chemotherapy on adverse events and hospital costs.. Journal of Clinical Oncology. 37(15_suppl). 3028–3028. 1 indexed citations

13.

Borrie, Adrienne E., Yun‐Hee Choi, Francisco Perera, et al.. (2018). Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer. Breast Cancer Research and Treatment. 172(2). 371–379. 11 indexed citations

14.

Winquist, Eric, Sara Kuruvilla, Anthony C. Nichols, et al.. (2018). Early mortality with immune checkpoint inhibitors (IOs) in solid tumors: An inconvenient truth?. Journal of Clinical Oncology. 36(15_suppl). 12121–12121. 2 indexed citations

15.

Welch, Stephen, Wendy A. Teft, John Lenehan, et al.. (2017). Abstract 5042: Defining an optimal single time point sampling strategy representative of overall capecitabine pharmacokinetics. Cancer Research. 77(13_Supplement). 5042–5042. 1 indexed citations

16.

Lenehan, John, Wendy A. Teft, & Richard B. Kim. (2016). Comparison of endoxifen levels between male and female breast cancer patients treated with tamoxifen.. Journal of Clinical Oncology. 34(15_suppl). 578–578. 4 indexed citations

17.

Teft, Wendy A., Stephen Welch, John Lenehan, et al.. (2015). OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy. British Journal of Cancer. 112(5). 857–865. 61 indexed citations

18.

Duncan, James S., Laszlo Gyenis, John Lenehan, et al.. (2008). An Unbiased Evaluation of CK2 Inhibitors by Chemoproteomics. Molecular & Cellular Proteomics. 7(6). 1077–1088. 71 indexed citations

19.

Lenehan, John, et al.. (2008). Women’s Knowledge, Attitudes, and Intentions Concerning Human Papillomavirus Vaccination: Findings of a Waiting Room Survey of Obstetrics-Gynaecology Outpatients. Journal of Obstetrics and Gynaecology Canada. 30(6). 489–499. 37 indexed citations

20.

Kwon, Janice S., John Lenehan, Mark Carey, & Peter Ainsworth. (2007). Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series. International Journal of Gynecological Cancer. 18(3). 546–549. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact